1 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
| 1 | 18326813 | Simultaneously targeting CD45 significantly increases cytotoxicity of the anti-CD33 immunoconjugate, gemtuzumab ozogamicin, against acute myeloid leukemia (AML) cells and improves survival of mice bearing human AML xenografts. | 2008 May 1 | 1 |